NCT02141971View on ClinicalTrials.gov

Down Syndrome Biomarker Initiative (DSBI)

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

June 1, 2013

Primary Completion Date

April 15, 2017

Study Completion Date

April 15, 2017

Conditions
Down SyndromeAlzheimer's Disease
Trial Locations (1)

92037

University of California, San Diego, La Jolla

All Listed Sponsors
collaborator

Janssen Research & Development, LLC

INDUSTRY

lead

Michael Rafii

OTHER

NCT02141971 - Down Syndrome Biomarker Initiative (DSBI) | Biotech Hunter | Biotech Hunter